Literature DB >> 14687626

Inhibitory effects of phaseolotoxin on proliferation of leukemia cells HL-60, K-562 and L1210 and pancreatic cells RIN-m5F.

André S Bachmann1, Ronghui Xu, Lal Ratnapala, Suresh S Patil.   

Abstract

Phaseolotoxin (PT) is a non-host specific phytotoxin produced by the plant pathogenic bacterium Pseudomonas syringae (P.s.) pv. phaseolicola. In the present study, the inhibitory effect of PT on the proliferation of leukemia cells was studied. After 4 days of treatment, PT decreased cell growth of leukemia cell lines HL-60, K-562 and L1210 in a dose-dependent manner. In addition, PT also reduced cell growth of the insulinoma pancreatic cell line RIN-m5F. IC50 values were 2.1 +/- 1.0 microM (HL-60), 13.3 +/- 3.7 microM (K-562), 2.5 +/- 0.4 microM (L1210) and 5.5 +/- 0.3 microM (RIN-m5F). Although the exact mechanism by which PT inhibits cell growth in these cells is currently not known, we present first evidence that PT may in part be active via inhibition of ornithine decarboxylase (ODC). Based on our findings, PT presents a lead compound with potential for further development into a new anti-cancer agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14687626     DOI: 10.1016/j.leukres.2003.07.002

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  3 in total

Review 1.  Polyamine synthesis as a target of MYC oncogenes.

Authors:  André S Bachmann; Dirk Geerts
Journal:  J Biol Chem       Date:  2018-11-07       Impact factor: 5.157

2.  Syringolin A, a new plant elicitor from the phytopathogenic bacterium Pseudomonas syringae pv. syringae, inhibits the proliferation of neuroblastoma and ovarian cancer cells and induces apoptosis.

Authors:  C S Coleman; J P Rocetes; D J Park; C J Wallick; B J Warn-Cramer; K Michel; R Dudler; A S Bachmann
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

3.  Accurate non-invasive image-based cytotoxicity assays for cultured cells.

Authors:  Patricia Marqués-Gallego; Hans den Dulk; Claude Backendorf; Jaap Brouwer; Jan Reedijk; Julian F Burke
Journal:  BMC Biotechnol       Date:  2010-06-17       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.